These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2863663)

  • 1. Heat inactivation of serum may interfere with HTLV-III/LAV serology.
    van den Akker R; Hekker AC; Osterhaus AD
    Lancet; 1985 Sep; 2(8456):672. PubMed ID: 2863663
    [No Abstract]   [Full Text] [Related]  

  • 2. Heat inactivation of serum may interfere with tests for antibodies to LAV/HTLV-III.
    van Beers D; Duys M; Maes M; Biarent D; Haumont D
    J Virol Methods; 1985 Dec; 12(3-4):329. PubMed ID: 3009518
    [No Abstract]   [Full Text] [Related]  

  • 3. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
    Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
    Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HTLV-III screening of blood donors.
    Kühnl P; Seidl S; Holzberger G
    Vox Sang; 1986; 51 Suppl 1():15-20. PubMed ID: 3017001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disinfection and inactivation of HTLV-III/LAV.
    Ronalds CJ; Grint PC; Kangro HD
    J Infect Dis; 1986 May; 153(5):996-7. PubMed ID: 3009641
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a new assay for antibodies to LAV/HTLV III.
    Maskill W; Healey D; Wootten A; Silvester C; Johnson S; O'Dwyer C; Jacklin R; Pringle R; Gust I; Harden P
    J Virol Methods; 1986 Jul; 13(4):273-8. PubMed ID: 3018016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-III antibody screening of blood bank donors.
    Lancet; 1985 Mar; 1(8427):523-4. PubMed ID: 2857890
    [No Abstract]   [Full Text] [Related]  

  • 8. HTLV-III/LAV infection in nine children infected by a single plasma donor: clinical outcome and recognition patterns of viral proteins.
    Lange JM; van den Berg H; Dooren LJ; Vossen JM; Kuis W; Goudsmit J
    J Infect Dis; 1986 Jul; 154(1):171-4. PubMed ID: 3011923
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell immunoperoxidase method for detecting HTLV-III antibodies.
    Lancet; 1985 Nov; 2(8463):1065-6. PubMed ID: 2865539
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
    Muncunill J; Forteza A; Forner N; Forteza-Rei J
    Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224
    [No Abstract]   [Full Text] [Related]  

  • 12. HTLV-III antibody in paid plasma donors in Spain.
    Hernandez JM; Argelagués E; Canivell M
    Lancet; 1985 Jun; 1(8442):1389. PubMed ID: 2861335
    [No Abstract]   [Full Text] [Related]  

  • 13. Photometric reading of anti-HTLV-III ELISA kits.
    Grunnet N; Jersild C; Georgsen J
    Lancet; 1985 Dec; 2(8467):1302. PubMed ID: 2866361
    [No Abstract]   [Full Text] [Related]  

  • 14. Which anti-HTLV III/LAV assays for screening and confirmatory testing?
    Mortimer PP; Parry JV; Mortimer JY
    Lancet; 1985 Oct; 2(8460):873-7. PubMed ID: 2864587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Search for HTLV-I and LAV/HTLV-III antibodies in serum and CSF of multiple sclerosis patients.
    De Rossi A; Gallo P; Tavolato B; Callegaro L; Chieco-Bianchi L
    Acta Neurol Scand; 1986 Aug; 74(2):161-4. PubMed ID: 3022528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to HTLV-III/LAV among aboriginal Amazonian Indians in Venezuela.
    Rodriquez L; Dewhurst S; Sinangil F; Merino F; Godoy G; Volsky DJ
    Lancet; 1985 Nov; 2(8464):1098-100. PubMed ID: 2865571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation].
    Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W
    Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results.
    Kühnl P; Seidl S; Holzberger G
    Lancet; 1985 May; 1(8439):1222-3. PubMed ID: 2860429
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for HTLV-III antibodies: the relation between prevalence and positive predictive value and its social consequences.
    JAMA; 1985 Jun; 253(23):3395-8. PubMed ID: 2987557
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-III antibody testing in three Danish blood banks.
    Orskov Lindhardt B; Ulrich K; Ryder L; Dickmeiss E; Sørensen H; Jørgensen J; Jersild C; Grunnet N
    Vox Sang; 1986; 51 Suppl 1():9-14. PubMed ID: 3017006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.